You just read:

ZIOPHARM and Intrexon Announce Cooperative Research and Development Agreement with the National Cancer Institute Utilizing Sleeping Beauty System to Generate T cells Targeting Neoantigens

News provided by

Intrexon Corporation , ZIOPHARM Oncology, Inc.

Jan 10, 2017, 08:00 ET